MRD allo transplantation using a large volume leukopheresis product mobilized with G-CSF and Decadron, pharmacokinetics directed modest dose intravenous busulfan plus fludarabine conditioning, and long MTX/CSA results in sustained engraftment, low 30 day mortality, and low incidence of severe GVHD.
Publication
, Journal Article
Vaughan, WP; Katz, RO; Salzman, DE; Tilden, AB; Lopez, RD; Garcia, A; Pena, O; Shackelford, M; Carabasi, MH
Published in: BLOOD
November 16, 2001
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 16, 2001
Volume
98
Issue
11
Start / End Page
200A / 200A
Publisher
AMER SOC HEMATOLOGY
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Vaughan, W. P., Katz, R. O., Salzman, D. E., Tilden, A. B., Lopez, R. D., Garcia, A., … Carabasi, M. H. (2001). MRD allo transplantation using a large volume leukopheresis product mobilized with G-CSF and Decadron, pharmacokinetics directed modest dose intravenous busulfan plus fludarabine conditioning, and long MTX/CSA results in sustained engraftment, low 30 day mortality, and low incidence of severe GVHD. BLOOD, 98(11), 200A-200A.
Vaughan, W. P., R. O. Katz, D. E. Salzman, A. B. Tilden, R. D. Lopez, A. Garcia, O. Pena, M. Shackelford, and M. H. Carabasi. “MRD allo transplantation using a large volume leukopheresis product mobilized with G-CSF and Decadron, pharmacokinetics directed modest dose intravenous busulfan plus fludarabine conditioning, and long MTX/CSA results in sustained engraftment, low 30 day mortality, and low incidence of severe GVHD.” BLOOD 98, no. 11 (November 16, 2001): 200A-200A.
Vaughan WP, Katz RO, Salzman DE, Tilden AB, Lopez RD, Garcia A, et al. MRD allo transplantation using a large volume leukopheresis product mobilized with G-CSF and Decadron, pharmacokinetics directed modest dose intravenous busulfan plus fludarabine conditioning, and long MTX/CSA results in sustained engraftment, low 30 day mortality, and low incidence of severe GVHD. BLOOD. 2001 Nov 16;98(11):200A-200A.
Vaughan, W. P., et al. “MRD allo transplantation using a large volume leukopheresis product mobilized with G-CSF and Decadron, pharmacokinetics directed modest dose intravenous busulfan plus fludarabine conditioning, and long MTX/CSA results in sustained engraftment, low 30 day mortality, and low incidence of severe GVHD.” BLOOD, vol. 98, no. 11, AMER SOC HEMATOLOGY, Nov. 2001, pp. 200A-200A.
Vaughan WP, Katz RO, Salzman DE, Tilden AB, Lopez RD, Garcia A, Pena O, Shackelford M, Carabasi MH. MRD allo transplantation using a large volume leukopheresis product mobilized with G-CSF and Decadron, pharmacokinetics directed modest dose intravenous busulfan plus fludarabine conditioning, and long MTX/CSA results in sustained engraftment, low 30 day mortality, and low incidence of severe GVHD. BLOOD. AMER SOC HEMATOLOGY; 2001 Nov 16;98(11):200A-200A.
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 16, 2001
Volume
98
Issue
11
Start / End Page
200A / 200A
Publisher
AMER SOC HEMATOLOGY
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology